| AAT | Anti-Amyloid Therapy |
| aAbs | Auto-Antibodies |
| AD | Alzheimer’s Disease |
| APOE | Apolipoprotein E |
| ARIA | Amyloid-Related Imaging Abnormalities |
| ARIA-E | Amyloid-Related Imaging Abnormalities with Edema/Effusion |
| ARIA-H | Amyloid-Related Imaging Abnormalities with Hemorrhages |
| BBB | Blood–Brain Barrier |
| CAA | Cerebral Amyloid Angiopathy |
| CMB | Cerebral Microbleeds |
| CSF | Cerebrospinal Fluid |
| cSS | Cortical superficial siderosis |
| iCAA | Iatrogenic Cerebral Amyloid Angiopathy |
| ICH | Intracerebral Hemorrhage |
| mAbs | Monoclonal Antibodies |
| TFNE | Transient Focal Neurological Episode |
| TREM2 | Triggering Receptor Expressed on Myeloid cells 2 |